MEDIC.AT Medicon Hellas S.A.

Healthcare Pharmaceuticals Athens Exchange
3.11 EUR
Close of Oct 27, 2026
2.39 3.12
Market cap
EUR 13.7M
P/E
18.2x
P/B
-
ROE
-
Dividend yield
0.77%
Fundamental score
1.3/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2023.

Is MEDIC.AT undervalued?

Graham number

The Graham number of Medicon Hellas S.A. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Medicon Hellas S.A. fundamental analysis

5 of 21 checks passed

ROE 0/2

ROE cannot be calculated: equity is negative or not reported.

ROA 0/1

Return on assets cannot be compared with the industry.

Profit Consistency 2/2

Profitable for 9 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-16.7%) is below the industry median (14.7%).

Revenue Growth 2/2

Revenue grew 15.6% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 0/1

Current assets do not cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Cash Runway 0/2

Cash runway cannot be calculated.

PE vs Market 0/1

PE (18.2x) is above the market median (12.7x).

PE vs Industry 0/1

PE (18.2x) is above the industry median (16.6x).

PBV 0/1

Price to book is negative or not available.

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

Dividend yield (0.8%) is in the bottom 25% of dividend payers in the market.

Dividend Stability 1/2

Dividends paid without a cut of more than 10% for 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 1/1

Payout ratio is 4.2%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Medicon Hellas S.A. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Medicon Hellas S.A.

Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer sysytem for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It also produces reagents for various analyzers, such as specific protein and hematol…

Full company profile